Skip to content
Log in
Sponsored AI AM CLAUDE, A Beginner's Guide: Learn the basics of working with AI AI AM CLAUDE, A Beginner's Guide: Learn the basics of working with AI

Author

Oladayo A. Oyebanji

View on Semantic Scholar

4 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Medicaid Expansion and Overall Mortality among Individuals with Renal Cell Carcinoma

Introduction: Renal cell carcinoma (RCC) remains a major cause to cancer-related morbidity, mortality, and economic burden in the United States. Medicaid expansion under the Affordable Care Act (ACA) increased access to insurance coverage for low-income adults, yet evidence regarding its impact on RCC survival remains...

Oluwasegun A. Akinyemi, Oladayo A. Oyebanji, M. Fasokun et al. · 0 citations
Aug 2026

Medicaid Expansion and Overall Mortality in Lung, Breast, and Colorectal Cancer: A Difference-in-Differences Study.

BackgroundMedicaid expansion under the Affordable Care Act (ACA) was designed to improve access to care for low-income adults, but its impact on cancer survival may vary across diseases depending on differences in screening, stage at diagnosis, and treatment pathways.MethodsWe conducted a retrospective cohort study usi...

Oluwasegun A. Akinyemi, J. Heath, Oladayo A. Oyebanji et al. · 0 citations
Aug 2026

Racial and Ethnic Disparities in Distant-Stage Presentation of Lung, Breast, and Colorectal Cancers, 2006-2021.

The largest inequities occur among Non-Hispanic Black patients with breast cancer despite the presence of long-standing population screening programs, suggesting that mechanisms beyond screening access-such as delays in diagnostic follow-up, barriers to care navigation, and structural inequities-contribute to persisten...

Oluwasegun A. Akinyemi, Keyline Moreno, Oladayo A. Oyebanji et al. · 0 citations
Open access Aug 2026

Comparative immunogenicity of mRNA-1273 and BNT162b2 SARS-CoV-2 bivalent booster vaccines in US nursing home residents

Both mRNA-1273 and BNT162b2 mRNA vaccines elicit similarly robust humoral immunity in NHRs, supporting their interchangeable use in booster strategies, and underscore the importance of timely booster administration over exact product selection in protecting this high-risk, immunosenescent population.

Olajide J. Olagunju, Oladayo A. Oyebanji, Debbie Keresztesy et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.